Compare Pfizer Inc (PFE) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Pfizer Inc trades at $28.17 (market cap $158.56B), while Vanguard Real Estate Index Fund ETF trades at $90.45 (market cap $70.80B). The key difference: Pfizer Inc is far larger — about 2.2× Vanguard Real Estate Index Fund ETF's market cap, and Pfizer Inc pays a 6.18% dividend while Vanguard Real Estate Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Vanguard Real Estate Index Fund ETF for 112 Days on average.
| PFE | VNQ | |
|---|---|---|
Market Cap | $158.56B | $70.80B |
Volume | 44,138,282 | 6,073,580 |
Sector | Health | — |
52-Week High | $29.02 | $100.95 |
52-Week Low | $23.67 | $87.00 |
Typical Hold Time | 158 Days | 112 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
VNQ trades at $90.02, up 1.5% today amid a bearish technical trend. The ETF faces pressure from rising Treasury yields, with moving averages signaling sell conditions. Recent news highlights institutional buying despite sector headwinds, as REITs grapple with interest rate sensitivity and valuation concerns. The dividend yield remains a focal point, though competition from T-bills challenges its income appeal.
Outlook: Near-term risks from Fed policy and sector rotation persist, but contrarian opportunities exist for long-term investors. Key risks include interest rate volatility and economic slowdowns, while potential upside hinges on rate stabilization and real estate demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
